CURRENT ISSUE HIGHLIGHTS

Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors

Published online May 16, 2025

Post-isotretinoin acne vulgaris relapse rates remain substantial, ranging from 20 to 60%. 1 Given these high rates, guidelines for pos...

Published online May 12, 2025

Dandruff is a common skin condition affecting up to half of the world’s population. Symptoms include pruritus, inflammation, and ...

Published online May 9, 2025

Isotretinoin has been used to treat severe acne vulgaris since the early 1980s. Initial studies demonstrated acne improvement with dosi...

Published online May 5, 2025

Seborrheic dermatitis is a chronic inflammatory skin condition with an estimated global prevalence of 4.38%. 1 The pathophysiology is ...

Published online April 30, 2025

The management of acne vulgaris is difficult owing to the chronic nature of the disease and frequent relapses. 1 As such, treatment du...

Published online April 30, 2025

Actinic Keratosis And Cryotherapy Actinic keratosis (AK) is a concern worldwide and is associated with an increased risk of developme...

Published online April 30, 2025

Basal and squamous cell carcinomas are the most common cancers in the United States with an alarming 80% increase in recent years. 1,2 ...

Published online April 28, 2025

Eruptive keratoacanthomas (KAs) and squamous cell carcinomas (SCCs) are recognized side effects of monotherapy with BRAF inhibitors. 1 ...

Published online April 28, 2025

Aging skin frequently shows a decrease in skin firmness/density and may be associated with erythema or uneven skin tone. 1 Often, agin...

Published online April 28, 2025

Basal cell carcinoma (BCC) is the most prevalent cancer worldwide.1 The mainstay of treatment is surgical excision or Mohs micrographic...

Published online April 29, 2025

Melanoma is a deadly malignancy with rising incidence rates over the past 50 years, especially in fairly complected individuals. 1 Sin...

Current Issue

Explore JDDonline

Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Exploring the Scope of Melanoma Educational Content on Instagram

Nadia Marcus | Featured Articles, Latest News, Skin Cancer, The Latest | No Comments

Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…

Journal of Drugs in Dermatology JDD Article About Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

Nadia Marcus | Featured Articles, Latest News, Skin Cancer, The Latest | No Comments

What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

CURRENT ISSUE HIGHLIGHTS

Published online May 16, 2025

Post-isotretinoin acne vulgaris relapse rates remain substantial, ranging from 20 to 60%. 1 Given these high rates, guidelines for pos...

Published online May 12, 2025

Dandruff is a common skin condition affecting up to half of the world’s population. Symptoms include pruritus, inflammation, and ...

Published online May 9, 2025

Isotretinoin has been used to treat severe acne vulgaris since the early 1980s. Initial studies demonstrated acne improvement with dosi...

Published online May 5, 2025

Seborrheic dermatitis is a chronic inflammatory skin condition with an estimated global prevalence of 4.38%. 1 The pathophysiology is ...

Published online April 30, 2025

The management of acne vulgaris is difficult owing to the chronic nature of the disease and frequent relapses. 1 As such, treatment du...

Published online April 30, 2025

Actinic Keratosis And Cryotherapy Actinic keratosis (AK) is a concern worldwide and is associated with an increased risk of developme...

Published online April 30, 2025

Basal and squamous cell carcinomas are the most common cancers in the United States with an alarming 80% increase in recent years. 1,2 ...

Published online April 28, 2025

Eruptive keratoacanthomas (KAs) and squamous cell carcinomas (SCCs) are recognized side effects of monotherapy with BRAF inhibitors. 1 ...

Published online April 28, 2025

Aging skin frequently shows a decrease in skin firmness/density and may be associated with erythema or uneven skin tone. 1 Often, agin...

Published online April 28, 2025

Basal cell carcinoma (BCC) is the most prevalent cancer worldwide.1 The mainstay of treatment is surgical excision or Mohs micrographic...

Published online April 29, 2025

Melanoma is a deadly malignancy with rising incidence rates over the past 50 years, especially in fairly complected individuals. 1 Sin...

Explore JDDonline

Latest News

News Topics

JDD Newsletter

JDD Podcast

Follow Us

News Topics

Journal of Drugs in Dermatology

Search